Now to an issue that continues to affect the Australian healthcare system, the scarcity of intravenous fluids. 

Updated modelling released by the Therapeutic Goods Administration last week found current shortages could last for at least the next six months.

On March 5, the Federal government announced a twenty million dollar investment to bolster capability at the only onshore manufacturer of saline solution in the country, Baxters

GUEST:

Danielle McMullen President of the Australian Medical Association